Skip to main content

Table 1 Characteristics of the study population at baseline

From: Fetuin-A levels are increased in the adipose tissue of diabetic obese humans but not in circulation

 

Obese diabetic

Obese non-diabetic

P value

Anthropometric and physical characteristics

 Gender (Male/Female)

118(64/54)

166 (67/99)

0.020

 Age (years)

52±9.4

40±11.6

<0.001

 BMI (kg/m2)

31.43 ±4.50

29.19 ±5.83

<0.001

 PBF (%)

36.60 ±8.08

34.42 ±6.70

0.015

 Waist (cm)

105.19 ±11.36

96.80 ±14.51

<0.001

 Hip (cm)

110.97 ±11.82

108.50 ±15.63

0.117

 WBC10

7.34 ±1.93

6.57 ±1.79

<0.001

 SBP (mmHg)

121.83 ±12.13

116.87 ±12.18

0.001

 DBP (mmHg)

77.28 ±7.47

76.15 ±8.11

0.210

 HR (beats/min)

82.52 ±13.04

78.55 ±11.17

0.006

 VO2, Max (ml/kg/min)

15.93 ±4.40

19.25 ±4.97

<0.001

Medication

 Anti-diabetic

  Metformin

72 %

1%

-

  Insulin

36%

-

-

  Sulfonylurea

20%

-

-

  DPP4 inhibitors

17%

-

-

  GLP1 analogues

3%

-

-

 Anti-hypertensive

57%

10%

-

 Lipid lowering

69%

8%

-

Metabolic markers

 Cholesterol (mmol/l)

4.98 ±1.29

5.07 ±0.92

0.489

 HDL (mmol/l)

1.17 ±0.43

1.29 ±0.40

0.009

 LDL (mmol/l)

3.07 ±1.24

3.21 ±0.85

0.205

 TG (mmol/l)

1.72 ±1.07

1.25 ±1.25

<0.001

 FBG (mmol/l)

9.04 ±3.64

5.30 ±0.72

<0.001

 HbA1c (%)

7.33 ±1.91

5.89 ±0.52

<0.001

 Insulin (ng/ml)

3.90 ±1.88

3.42 ±1.99

0.072

 C-pep (ng/ml)

3.98 ±5.26

5.12 ±6.12

0.135

 hsCRP (μg/ml)

5.67 ±4.31

4.63 ±4.36

0.109

 Fetuin-A (mg/ml)

1.27 ±0.33

1.15 ±0.34

0.070

  1. Data are presented as mean ± SD. PBF Percent body fat, BMI Body mass index, SBP Systolic blood pressure, DBP Diastolic blood pressure, LDL Low density lipoprotein, TG Triglycerides, HDL High density lipoprotein, C-pep C-peptide, hsCRP High-sensitive C-Reactive Protein. Nonparametric Mann-Whitney test was used to determine significance of difference in means between obese diabetic and obese non-diabetic groups
  2. Bold text: p-value <0.05